These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 26395174)

  • 41. The Efficacy of Perindopril/Amlodipine in Reaching Blood Pressure Targets: Results of the CONTROL Study.
    Abdelhady A; Khader S; Sinnuqrut S; Albow A
    Clin Drug Investig; 2016 May; 36(5):357-66. PubMed ID: 26832739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Fimasartan/Amlodipine Combined Therapy Versus Fimasartan Monotherapy in Patients With Essential Hypertension Unresponsive to Fimasartan Monotherapy.
    Kim KI; Shin MS; Ihm SH; Youn HJ; Sung KC; Chae SC; Nam CW; Seo HS; Park SM; Rhee MY; Kim MH; Cha KS; Kim YJ; Kim JJ; Chun KJ; Yoo BS; Park S; Shin ES; Kim DS; Il Kim D; Kim KH; Joo SJ; Jeong JO; Shin J; Kim CH
    Clin Ther; 2016 Oct; 38(10):2159-2170. PubMed ID: 27502326
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy of an amlodipine/olmesartan treatment algorithm in patients with or without type 2 diabetes and hypertension (a secondary analysis of the BP-CRUSH study).
    Nesbitt SD; Shojaee A; Maa JF; Weir MR
    J Hum Hypertens; 2013 Jul; 27(7):445-52. PubMed ID: 23254596
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term effects of perindopril-amlodipine vs perindopril-indapamide on blood pressure control in sub-Saharan type 2 diabetic individuals newly diagnosed for hypertension: A double-blinded randomized controlled trial.
    Sobngwi E; Mfeukeu-Kuate L; Kouam M; Tankeu AT; Nganou-Gnindjio CN; Hamadou B; Etoa M; Ngassam E; Nkamgna A; Dehayem MY; Kaze FF; Kengne AP; Mbanya JC
    J Clin Hypertens (Greenwich); 2019 Jul; 21(7):1002-1008. PubMed ID: 31175711
    [TBL] [Abstract][Full Text] [Related]  

  • 45. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study.
    Bobrie G;
    Clin Ther; 2012 Aug; 34(8):1720-34.e3. PubMed ID: 22853847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 24-hour efficacy and safety of Triple-Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: the TRINITY ambulatory blood pressure substudy.
    Izzo JL; Chrysant SG; Kereiakes DJ; Littlejohn Iii T; Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
    J Clin Hypertens (Greenwich); 2011 Dec; 13(12):873-80. PubMed ID: 22142346
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of hypertension with the fixed combination of perindopril and amlodipine in daily clinical practice: results from the STRONG prospective, observational, multicenter study.
    Bahl VK; Jadhav UM; Thacker HP
    Am J Cardiovasc Drugs; 2009; 9(3):135-42. PubMed ID: 19463019
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Barrios V; Brommer P; Haag U; Calderón A; Escobar C
    Clin Drug Investig; 2009; 29(7):427-439. PubMed ID: 19499960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Optimization of treatment in hypertensive patients in real clinical practice: Role of a fixed-dose perindopril A and amlodipine combination (Results of the Russian observational CONSTANTA trial].
    Kobalava ZD; Kotovskaya YV; Khodorovich NA
    Ter Arkh; 2015; 87(3):66-70. PubMed ID: 26027243
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Olmesartan Combined With Amlodipine on Oxidative Stress Parameters in Type 2 Diabetics, Compared With Single Therapies: A Randomized, Controlled, Clinical Trial.
    Derosa G; Mugellini A; Pesce RM; D'Angelo A; Maffioli P
    Medicine (Baltimore); 2016 Mar; 95(13):e3084. PubMed ID: 27043671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the efficacy and tolerability of fixed-dose combination therapy of azilsartan and amlodipine besylate in Japanese patients with grade I to II essential hypertension.
    Rakugi H; Nakata E; Sasaki E; Kagawa T
    Clin Ther; 2014 May; 36(5):711-21. PubMed ID: 24742498
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Blood pressure control and acceptability of perindopril and its fixed dose combinations with amlodipine or indapamide, in younger patients with hypertension.
    Bansal S; Chauhan DK; Ramesh D; Barmare S; Chakraborty S
    Indian Heart J; 2014; 66(6):635-9. PubMed ID: 25634398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and tolerability of amlodipine camsylate/losartan 5/100-mg versus losartan/hydrochlorothiazide 100/12.5-mg fixed-dose combination in hypertensive patients nonresponsive to losartan 100-mg monotherapy.
    Suh SY; Ahn T; Bae JH; Lim DS; Lee SU; Kim YK; Hyon MS; Kim WH; Han KR; Park HK
    Clin Ther; 2014 Oct; 36(10):1402-11. PubMed ID: 25146365
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy and Tolerability of Combination Therapy Versus Monotherapy with Candesartan and/or Amlodipine for Dose Finding in Essential Hypertension: A Phase II Multicenter, Randomized, Double-blind Clinical Trial.
    Sohn IS; Kim CJ; Ahn T; Youn HJ; Jeon HK; Ihm SH; Cho EJ; Chung WB; Chae SC; Kim WS; Nam CW; Park SM; Choi JY; Kim YK; Hong TJ; Lee HY; Cho JH; Shin ES; Yoon JH; Yang TH; Jeong MH; Lee JH; Park JI
    Clin Ther; 2017 Aug; 39(8):1628-1638. PubMed ID: 28734660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Switching from a Free Association of Perindopril/Amlodipine to a Fixed-Dose Combination: Increased Antihypertensive Efficacy and Tolerability.
    Hatalova K; Pella D; Sidlo R; Hatala R
    Clin Drug Investig; 2016 Jul; 36(7):591-8. PubMed ID: 27113228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of amlodipine/olmesartan medoxomil ± hydrochlorothiazide in patients aged ≥ 65 or < 65 years with uncontrolled hypertension on prior monotherapy.
    Weir MR; Shojaee A; Maa JF
    Postgrad Med; 2013 Mar; 125(2):124-34. PubMed ID: 23816778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients.
    Destro M; Crikelair N; Yen J; Glazer R
    Vasc Health Risk Manag; 2010 Sep; 6():821-7. PubMed ID: 20859551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice.
    Bramlage P; Wolf WP; Stuhr T; Fronk EM; Erdlenbruch W; Ketelhut R; Schmieder RE
    Vasc Health Risk Manag; 2010 Sep; 6():803-11. PubMed ID: 20859549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Twenty-four-hour ambulatory blood pressure reduction with a perindopril/amlodipine fixed-dose combination.
    Nagy VL
    Clin Drug Investig; 2013 Jul; 33(7):469-76. PubMed ID: 23681954
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antihypertensive efficacy of triple combination perindopril/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients).
    Tóth K;
    Am J Cardiovasc Drugs; 2014 Apr; 14(2):137-45. PubMed ID: 24590580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.